Essential to read from the editorial board

This issue features several important original papers as well as comprehensive reviews. Effective management of inflammatory bowel diseases (IBD) requires regular assessment of patient-reported outcomes (PROs) and daily life factors to enhance disease control. Technological advancements now enable more frequent and accurate capture of PROs and quality-oflife metrics. Studies suggest that telemonitoring is wellaccepted in IBD care and can improve clinical outcomes while reducing costs in the short term (1). Delhougne et al. present a single-centre prospective study exploring the feasibility of telemonitoring using a connected watch and/ or mobile application. This system assesses PROs related to both gastrointestinal and extra-intestinal symptoms, as well as mental well-being and productivity. The study found that while patients showed good acceptance of the approach and clinicians recognised the value of capturing PROs more comprehensively, adherence and feasibility were suboptimal. These findings suggest that the tools require further refinement to ensure consistent use, improve usability, and optimise patient selection for routine clinical application.